These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2323662)

  • 1. Treatment of relapsed or refractory acute leukemia: comparison of two different regimens.
    Marit G; Cony P; Duclos F; Puntous M; Broustet A; Reiffers J
    Haematol Blood Transfus; 1990; 33():614-8. PubMed ID: 2323662
    [No Abstract]   [Full Text] [Related]  

  • 2. Sequential pilot studies of intensive postremission chemotherapy for acute nonlymphocytic leukemia.
    Petti MC; Avvisati G; Tafuri A; Meloni G; Amadori S; Mandelli F
    Ann N Y Acad Sci; 1987; 511():436-41. PubMed ID: 3326472
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacology of cytarabine given as a continuous infusion followed by mitoxantrone with and without amsacrine/etoposide as reinduction chemotherapy for relapsed or refractory pediatric acute myeloid leukemia.
    Ozkaynak MF; Avramis VI; Carcich S; Ortega JA
    Med Pediatr Oncol; 1998 Dec; 31(6):475-82. PubMed ID: 9835899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of a multicenter treatment program including autologous or allogeneic bone marrow transplantation for de novo acute myeloid leukemia.
    Wahlin A; Brinch L; Hörnsten P; Evensen SA; Oberg G; Simonsson B; Hedenus M
    Eur J Haematol; 1997 Apr; 58(4):233-40. PubMed ID: 9186533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.
    Wells RJ; Adams MT; Alonzo TA; Arceci RJ; Buckley J; Buxton AB; Dusenbery K; Gamis A; Masterson M; Vik T; Warkentin P; Whitlock JA;
    J Clin Oncol; 2003 Aug; 21(15):2940-7. PubMed ID: 12885813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission induction and postremission therapy in acute myelogenous leukemia: British MRC Study.
    Rees JK; Gray RG
    Haematol Blood Transfus; 1990; 33():243-8. PubMed ID: 1691131
    [No Abstract]   [Full Text] [Related]  

  • 7. Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia.
    Lee SS; Lee JH; Lee JH; Kim DY; Kim SH; Lim SN; Lee YS; Seol M; Ryu SG; Kang YA; Jang S; Park CJ; Chi HS; Yun SC; Lee KH
    Leuk Res; 2009 Apr; 33(4):511-7. PubMed ID: 18819710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoxantrone and continuous infusion of cytosine arabinoside in refractory and relapsed acute lymphoblastic leukemia.
    Liso V; Specchia G; Capalbo S; Pavone V; Iacobazzi A; Iaculli ML; Dione R; Pansini N
    Acta Haematol; 1992; 87(1-2):54-7. PubMed ID: 1585771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAVC regimen in CR AML patients.
    Meloni G; Vignetti M; De Fabritiis P; Petti MC; Pinto MR; Testi AM; Vegna ML; Mandelli F
    Bone Marrow Transplant; 1991; 7 Suppl 2():134. PubMed ID: 1878679
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined chemotherapy with m-amsacrine in high-risk patients with acute non-lymphocytic leukemia.
    Maschmeyer G; Hiddemann W; Kreutzmann H; Wendt F
    Onkologie; 1987 Feb; 10(1):18-21. PubMed ID: 3295621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double intensive consolidation chemotherapy (ICC) for acute myeloid leukemia.
    Harousseau JL; Milpied N; Briere J; Desablens B; Le Prise PY; Ifrah N; Gandhour C; Casassus P
    Haematol Blood Transfus; 1990; 33():299-303. PubMed ID: 2323633
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia.
    Sung WJ; Kim DH; Sohn SK; Kim JG; Baek JH; Jeon SB; Moon JH; Ahn BM; Lee KB
    Jpn J Clin Oncol; 2005 Oct; 35(10):612-6. PubMed ID: 16172175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy for acute myelogenous leukemia.
    Kalaycio M
    Curr Hematol Rep; 2005 Jan; 4(1):49-50. PubMed ID: 15610659
    [No Abstract]   [Full Text] [Related]  

  • 14. Mitoxantrone, etoposide, carboplatinum and ara-C combination therapy (MECA) in refractory and relapsed acute leukemia.
    Ferrá C; Berlanga JJ; Gallardo D; Ancín I; Marín D; González JR; Peris J; Muñoz J; Sarrá J; Grañena A
    Leuk Lymphoma; 2000 Nov; 39(5-6):583-90. PubMed ID: 11342341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.
    Martino R; Guardia R; Altés A; Sureda A; Brunet S; Sierra J
    Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonhematologic toxicities of selected chemotherapeutic agents used in the treatment of adult leukemia.
    Cunningham M
    Semin Oncol Nurs; 1990 Feb; 6(1):67-75. PubMed ID: 2406830
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of etoposide and mitoxantrone in patients with acute myelogenous leukemia refractory to standard induction therapy and intermediate-dose cytarabine with amsidine. Dutch Hematology-Oncology Working Group for Adults (HOVON).
    Daenen S; Löwenberg B; Sonneveld P; van Putten WL; Verhoef G; Verdonck LF; van Veldhoven M; Huijgens PC
    Leukemia; 1994 Jan; 8(1):6-10. PubMed ID: 8289499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage therapy for relapsed or refractory childhood acute lymphocytic leukemia by alternative administration a lymphoid- and myeloid-directed chemotherapeutic regimen consisting of dual modulation of ara-C, hydroxyurea, and etoposide.
    Higashigawa M; Hori H; Hirayama M; Kawasaki H; Ido M; Azuma E; Sakurai M
    Leuk Res; 1997 Sep; 21(9):811-5. PubMed ID: 9393595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The current chemotherapy of acute myeloid leukemias in adults].
    Poddubnaia IV; Perilov AA
    Ter Arkh; 1993; 65(7):86-9. PubMed ID: 8211791
    [No Abstract]   [Full Text] [Related]  

  • 20. Autologous bone marrow transplantation for patients with acute myelogenous leukemia in complete remission.
    Meloni G; De Fabritiis P; Petti MC; Pulsoni A; Sandrelli A; Covelli A; Simone F; Mandelli F
    Ann N Y Acad Sci; 1987; 511():483-8. PubMed ID: 3326477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.